Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya
Panton–Valentine leukocidin gene is produced by Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus isolates as a pore-forming toxin is largely responsible for skin and soft tissue illnesses. MRSA produces PVL toxins through lukS and lukF proteins causing tissue necrosis by damagi...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | International Journal of Microbiology |
Online Access: | http://dx.doi.org/10.1155/2020/3106747 |
id |
doaj-5025859bcadd4142b0b8a3e8ffb5b9e6 |
---|---|
record_format |
Article |
spelling |
doaj-5025859bcadd4142b0b8a3e8ffb5b9e62021-07-02T12:53:58ZengHindawi LimitedInternational Journal of Microbiology1687-918X1687-91982020-01-01202010.1155/2020/31067473106747Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, KenyaSani Iliya0Jonathan Mwangi1Ronald Maathai2Mary Muriuki3Christopher Wainaina4Department of Biological Sciences, School of Pure and Applied Sciences, Mount Kenya University, Thika, KenyaSchool of Pharmacy and Health Sciences, United States International University-Africa, Nairobi, KenyaDepartment of Biochemistry, Mount Kenya University, Thika, KenyaSchool of Pure and Applied Sciences, Mount Kenya University, Thika, KenyaHain Life Science East Africa Ltd., Nairobi, KenyaPanton–Valentine leukocidin gene is produced by Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus isolates as a pore-forming toxin is largely responsible for skin and soft tissue illnesses. MRSA produces PVL toxins through lukS and lukF proteins causing tissue necrosis by damaging membrane of the defense cells. Presence of PVL toxin was tested from the 54 S. aureus clinical isolates obtained from Thika and Kiambu Level 5 Hospitals, in Kiambu County, Kenya, by Geno Type® MRSA assay (Hain Life Science, Nehren, Germany). DNA was isolated from freshly harvested bacterial cultures by spin column using Geno Type DNA isolation kit. The detection of PVL toxins was performed by amplification of genomic DNA and by reverse hybridization that identifies PVL genes using Geno Type MRSA kit. Out of 138 samples that were collected from patients in Kiambu County, 54 S. aureus isolates were obtained, of which 14 (25.9%; 95% CI = 11.9–38.9) samples had PVL toxins. The isolates that were obtained from the female patients had a higher PVL toxin prevalence of 35.7%, while the isolates collected from the male patients had a lower prevalence of 15.4% (P=0.09). The pediatrics department had the highest PVL gene prevalence compared to outpatient department and surgical units (P=0.08). However, the age groups of patients and the hospital attended by patients showed no significant difference in terms of PVL gene prevalence (P=0.26). Therefore, the patients' gender and hospital units were not significantly associated with PVL gene prevalence (P=0.08). This study shows that PVL positive isolates occur in the sampled hospitals in the county and female as well as children must be taken into consideration among patients with wound infections when isolating S. aureus.http://dx.doi.org/10.1155/2020/3106747 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sani Iliya Jonathan Mwangi Ronald Maathai Mary Muriuki Christopher Wainaina |
spellingShingle |
Sani Iliya Jonathan Mwangi Ronald Maathai Mary Muriuki Christopher Wainaina Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya International Journal of Microbiology |
author_facet |
Sani Iliya Jonathan Mwangi Ronald Maathai Mary Muriuki Christopher Wainaina |
author_sort |
Sani Iliya |
title |
Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya |
title_short |
Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya |
title_full |
Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya |
title_fullStr |
Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya |
title_full_unstemmed |
Molecular Detection of Panton Valentine Leukocidin Toxin in Clinical Isolates of Staphylococcus aureus from Kiambu County, Kenya |
title_sort |
molecular detection of panton valentine leukocidin toxin in clinical isolates of staphylococcus aureus from kiambu county, kenya |
publisher |
Hindawi Limited |
series |
International Journal of Microbiology |
issn |
1687-918X 1687-9198 |
publishDate |
2020-01-01 |
description |
Panton–Valentine leukocidin gene is produced by Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus isolates as a pore-forming toxin is largely responsible for skin and soft tissue illnesses. MRSA produces PVL toxins through lukS and lukF proteins causing tissue necrosis by damaging membrane of the defense cells. Presence of PVL toxin was tested from the 54 S. aureus clinical isolates obtained from Thika and Kiambu Level 5 Hospitals, in Kiambu County, Kenya, by Geno Type® MRSA assay (Hain Life Science, Nehren, Germany). DNA was isolated from freshly harvested bacterial cultures by spin column using Geno Type DNA isolation kit. The detection of PVL toxins was performed by amplification of genomic DNA and by reverse hybridization that identifies PVL genes using Geno Type MRSA kit. Out of 138 samples that were collected from patients in Kiambu County, 54 S. aureus isolates were obtained, of which 14 (25.9%; 95% CI = 11.9–38.9) samples had PVL toxins. The isolates that were obtained from the female patients had a higher PVL toxin prevalence of 35.7%, while the isolates collected from the male patients had a lower prevalence of 15.4% (P=0.09). The pediatrics department had the highest PVL gene prevalence compared to outpatient department and surgical units (P=0.08). However, the age groups of patients and the hospital attended by patients showed no significant difference in terms of PVL gene prevalence (P=0.26). Therefore, the patients' gender and hospital units were not significantly associated with PVL gene prevalence (P=0.08). This study shows that PVL positive isolates occur in the sampled hospitals in the county and female as well as children must be taken into consideration among patients with wound infections when isolating S. aureus. |
url |
http://dx.doi.org/10.1155/2020/3106747 |
work_keys_str_mv |
AT saniiliya moleculardetectionofpantonvalentineleukocidintoxininclinicalisolatesofstaphylococcusaureusfromkiambucountykenya AT jonathanmwangi moleculardetectionofpantonvalentineleukocidintoxininclinicalisolatesofstaphylococcusaureusfromkiambucountykenya AT ronaldmaathai moleculardetectionofpantonvalentineleukocidintoxininclinicalisolatesofstaphylococcusaureusfromkiambucountykenya AT marymuriuki moleculardetectionofpantonvalentineleukocidintoxininclinicalisolatesofstaphylococcusaureusfromkiambucountykenya AT christopherwainaina moleculardetectionofpantonvalentineleukocidintoxininclinicalisolatesofstaphylococcusaureusfromkiambucountykenya |
_version_ |
1721329651474759680 |